Rory B. Riggs - Mar 17, 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Jason Mehar, as Attorney-in-Fact for Rory B. Riggs
Stock symbol
RPRX
Transactions as of
Mar 17, 2022
Transactions value $
-$6,667,521
Form type
4
Date filed
3/21/2022, 06:20 PM
Previous filing
Mar 18, 2022
Next filing
Mar 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Other +4.9K +0.83% 598K Mar 17, 2022 Direct F1, F2
transaction RPRX Class A Ordinary Shares Other +64.1K +10.72% 662K Mar 17, 2022 Direct F2, F3
transaction RPRX Class A Ordinary Shares Other -230K -76.04% 72.3K Mar 17, 2022 By New Ventures Select F4
transaction RPRX Class A Ordinary Shares Other -1.08M -96.36% 40.6K Mar 17, 2022 By New Ventures I LLC F5
transaction RPRX Class A Ordinary Shares Other -532K -79% 141K Mar 17, 2022 By New Ventures III LLC F6
transaction RPRX Class A Ordinary Shares Sale -$1.84M -46.8K -64.69% $39.38 25.5K Mar 18, 2022 By New Ventures Select F7
transaction RPRX Class A Ordinary Shares Sale -$1.03M -26.2K -64.69% $39.38 14.3K Mar 18, 2022 By New Ventures I LLC F7
transaction RPRX Class A Ordinary Shares Sale -$2.23M -56.2K -39.74% $39.77 85.2K Mar 18, 2022 By New Ventures III LLC F8
transaction RPRX Class A Ordinary Shares Sale -$998K -25.5K -100% $39.05 0 Mar 21, 2022 By New Ventures Select F9
transaction RPRX Class A Ordinary Shares Sale -$559K -14.3K -100% $39.05 0 Mar 21, 2022 By New Ventures I LLC F9
holding RPRX Class A Ordinary Shares 15K Mar 17, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution from New Ventures Select, of which the Reporting Person has voting and investment control.
F2 Pro rata distribution from a limited liability company of which the Reporting Person is a member.
F3 Pro rata distribution from New Ventures I LLC, of which the Reporting Person has voting and investment control.
F4 New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.
F5 New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.
F6 New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.20 to $39.70 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.21 to $39.71 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.71 to $39.30 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.